He noted the enduring relevance of Siddha medicine as “a comprehensive, preventive and sustainable healthcare system in the contemporary world
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The company also reported significant progress toward its internally defined Sustainable Development Goals
The company along with its subsidiaries has overall bed capacity of 8800+ beds as on 30th September, 2025
Tablets will be manufactured at Granules' US-based facility located in Chantilly, Virginia
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
The inspection concluded with one minor observation in Form 483
The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Subscribe To Our Newsletter & Stay Updated
